Amcor plc (A1CR34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 20 Oct 2026
Key indicators
| Last close | BRL 222.30 |
|---|---|
| 52-week range | 178.96 – 261.58 |
| Return, 1 month / 3 months | +2.2% / +2.2% |
| Return, 1 year / 3 years | +4.6% / +7.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 60 |
| Volatility (1 year) | 36.8% |
| Worst drawdown (1 year) | -31.6% |
| Average daily value traded | 0.00M BRL |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Amcor plc is a packaging company based in Switzerland that makes both flexible and rigid packaging for customers around the world. Its products include plastic films, pouches, bottles, closures and containers used by food, beverage, healthcare, personal care and household goods manufacturers. The company supplies packaging materials and designs to consumer goods producers and healthcare companies, helping them package and protect their products for retail and institutional markets.
Amcor plc is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code A1CR34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Amcor plc (A1CR34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 222.30 on 20 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 719 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.6% and over the last three months it rose 2.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.7% | ||
| From 52-week high | -15.0% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.2% | ||
| 6-month return | 12.4% | ||
| 12-month return, skipping the last month | 2.4% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.6% | ||
| Liquidity | 18 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M BRL | ||
| Zero-volume days | 65.0% | ||
| Income | 65 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +7.0% |
|---|---|
| 1 month | +2.2% |
| 3 months | +2.2% |
| 6 months | +12.4% |
| 1 year | +4.6% |
| 3 years | +7.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 224.75 / 216.36 |
|---|---|
| Golden / death cross (60 days) | Golden, 48 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 May 2026 | CHF 3.2400 |
| 23 Feb 2026 | CHF 3.2728 |
| 26 Nov 2025 | CHF 0.6944 |
| 3 Sep 2025 | CHF 0.6584 |
| 20 May 2025 | CHF 0.6824 |
| 24 Feb 2025 | CHF 0.6980 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.